Star Combo Pharma Limited (ASX:S66)
Australia · Delayed Price · Currency is AUD 0.1400
0.00 (0.00%)
Sep 3, 2026, 4:10 PM AEST
Star Combo Pharma Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 3.91 | 3.59 | 2.16 | 2.99 | 4.39 |
Short-Term Investments | 14.1 | 14.52 | 5.2 | 6.5 | 6 |
Cash & Short-Term Investments | 18.01 | 18.11 | 7.36 | 9.49 | 10.39 |
Cash Growth | -0.56% | 146.14% | -22.44% | -8.71% | -40.01% |
Accounts Receivable | 1.71 | 2.03 | 4.19 | 3.79 | 1.98 |
Other Receivables | 1.63 | 0.35 | 0.29 | 0.28 | 0.76 |
Receivables | 3.35 | 2.38 | 4.48 | 4.07 | 2.75 |
Inventory | 3.42 | 4.97 | 6.34 | 4.2 | 5.37 |
Other Current Assets | 0.4 | 0.32 | 0.17 | 0.34 | 0.57 |
Total Current Assets | 25.18 | 25.79 | 18.35 | 18.1 | 19.08 |
Property, Plant & Equipment | 24 | 21.6 | 23.1 | 22.72 | 22.74 |
Other Intangible Assets | 0.67 | 0.67 | 0.68 | 0.69 | 0.7 |
Long-Term Deferred Tax Assets | 0.26 | 0.39 | 0.68 | 0.71 | 0.92 |
Other Long-Term Assets | - | - | -0 | - | - |
Total Assets | 50.11 | 48.45 | 42.82 | 42.23 | 43.44 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 3.45 | 3.95 | 2.82 | 2.44 | 2.34 |
Current Portion of Long-Term Debt | 0.02 | 0.02 | 0.01 | 0.04 | 0.04 |
Current Portion of Leases | 0.28 | 0.17 | 0.15 | 0.13 | 0.13 |
Current Income Taxes Payable | - | - | 0.23 | - | - |
Other Current Liabilities | 2.77 | 1.72 | 1.67 | 1.73 | 1.5 |
Total Current Liabilities | 6.53 | 5.86 | 4.87 | 4.33 | 4.01 |
Long-Term Debt | 0.01 | 0.04 | - | 0.01 | 0.08 |
Long-Term Leases | 3.88 | 3.71 | 3.87 | 4.02 | 3.87 |
Long-Term Deferred Tax Liabilities | 0.78 | 0.54 | 0.54 | 0.54 | 0.02 |
Other Long-Term Liabilities | 0.07 | 0.05 | 0.03 | 0.07 | 0.06 |
Total Liabilities | 11.28 | 10.19 | 9.3 | 8.97 | 8.04 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 67.29 | 67.29 | 67.29 | 67.29 | 67.22 |
Retained Earnings | -5.31 | -5.32 | -10.08 | -10.31 | -7.06 |
Comprehensive Income & Other | -23.15 | -23.89 | -23.89 | -23.89 | -24.75 |
Total Common Equity | 38.83 | 38.08 | 33.32 | 33.09 | 35.41 |
Minority Interest | - | 0.19 | 0.19 | 0.17 | - |
Shareholders' Equity | 38.83 | 38.26 | 33.51 | 33.26 | 35.41 |
Total Liabilities & Equity | 50.11 | 48.45 | 42.82 | 42.23 | 43.44 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 4.19 | 3.93 | 4.03 | 4.19 | 4.12 |
Net Cash (Debt) | 13.82 | 14.18 | 3.33 | 5.3 | 6.27 |
Net Cash Growth | -2.53% | 325.81% | -37.12% | -15.56% | -55.29% |
Net Cash Per Share | 0.10 | 0.10 | 0.02 | 0.04 | 0.05 |
Filing Date Shares Outstanding | 135.08 | 135.08 | 135.08 | 135.08 | 134.58 |
Total Common Shares Outstanding | 135.08 | 135.08 | 135.08 | 135.08 | 134.58 |
Working Capital | 18.65 | 19.93 | 13.48 | 13.77 | 15.07 |
Book Value Per Share | 0.29 | 0.28 | 0.25 | 0.24 | 0.26 |
Tangible Book Value | 38.17 | 37.41 | 32.65 | 32.4 | 34.71 |
Tangible Book Value Per Share | 0.28 | 0.28 | 0.24 | 0.24 | 0.26 |
Land | 7.5 | 6.07 | 6.07 | 6.05 | 3.91 |
Machinery | 14.59 | 6.98 | 6.8 | 4.93 | 3.09 |
Construction In Progress | 1.8 | 0.29 | 0.8 | 8.28 | 13.08 |
Leasehold Improvements | 2.22 | 9.52 | 9.3 | 2.28 | 1.01 |